Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 10, 2006, Pages 997-1001

  Palm, Fredrik ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diabetes; Kidney; Nephropathy; Nitric oxide; Oxygen consumption; Oxygen tension; Reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; POLYOL; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

CELL FUNCTION; CLINICAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENE; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; HYPOTHESIS; IN VIVO STUDY; KIDNEY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; METABOLISM; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; OXYGENATION; PATHOPHYSIOLOGY; REVIEW; TISSUE OXYGENATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; HUMANS; HYPERGLYCEMIA; HYPOXIA-INDUCIBLE FACTOR 1; KIDNEY; MODELS, BIOLOGICAL; OXIDATIVE STRESS; OXYGEN; OXYGEN CONSUMPTION; RENAL CIRCULATION; TRANSCRIPTION FACTORS;

EID: 33748909141     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04473.x     Document Type: Review

References (50)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993; 329: 977-86.
2. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am. J. Physiol. 1996; 270: G541-53.
3. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
4. Salahudeen AK, Kanji V, Reckelhoff JF, Schmidt AM. Pathogenesis of diabetic nephropathy: A radical approach. Nephrol. Dial. Transplant. 1997; 12: 664-8.
5. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 282: R335-42.
6. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-60.
7. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 2004; 47: 1223-31.
8. Buerk DG. Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities. Annu. Rev. Biomed. Eng. 2001; 3: 109-43.
9. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: Effects on renal oxygenation and microcirculation. Diabetes 2005; 54: 3282-7.
10. Koivisto A, Pittner J, Froelich M, Persson AE. Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int. 1999; 55: 2368-75.
11. Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J. Biol. Chem. 2002; 277: 47 129-35.
12. Semenza GL. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J. Lab. Clin. Med. 1998; 131: 207-14.
13. Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-90.
14. Asaba K, Tojo A, Onozato ML et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005; 67: 1890-8.
15. Satoh M, Fujimoto S, Haruna Y et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2005; 288: F1144-52.
16. O'Rourke B, Cortassa S, Aon MA. Mitochondrial ion channels: Gatekeepers of life and death. Physiology 2005; 20: 303-15.
17. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy. Effects of ACEI and ARB. Kidney Int. 2002; 61: 186-94.
18. Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler. Suppl. 2003; 4: 41-51.
19. Zatz R, de Nucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am. J. Physiol. 1991; 261: F360-3.
20. Walder CE, Thiemermann C, Vane JR. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br. J. Pharmacol. 1991; 102: 967-73.
21. Moncada S, Palmer RM, Higgs EA. Nitric oxide. Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-42.
22. Ohishi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. 1992; 263: F900-6.
23. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S. Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J. Clin. Invest. 1991; 88: 390-5.
24. Epstein FH. Oxygen and renal metabolism. Kidney Int. 1997; 51: 381-5.
25. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994; 356: 295-8.
26. Hallemeesch MM, Lamers WH, Deutz NE. Reduced arginine availability and nitric oxide production. Clin. Nutr. 2002; 21: 273-9.
27. Boger RH. Asymmetric dimethylarginine (ADMA) modulates endothelial function: Therapeutic implications. Vasc. Med. 2003; 8: 149-51.
28. Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 2004; 27: 765-9.
29. Lin KY, Ito A, Asagami T et al. Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002; 106: 987-92.
30. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am. J. Physiol. Renal Physiol. 2003; 284: F1121-37.
31. Thomson SC, Deng A, Komine N, Hammes JS, Blantz RC, Gabbai FB. Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am. J. Physiol. Renal Physiol. 2004; 287: F732-8.
32. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994; 43: 629-33.
33. 2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules. Am. J. Physiol. Renal Physiol. 2002; 283: F286-93.
34. Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand. J. Clin. Lab. Invest. 1971; 28: 177-82.
35. Palm F, Liss P, Fasching A, Hansell P, Carlsson PO. Transient glomerular hyperfiltration in the streptozotocin-diabetic Wistar Furth rat. Upsalla J. Med. Sci. 2001; 106: 175-82.
36. O'Donnell MP, Kasiske BL, Keane WF. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 1988; 2: 2339-47.
37. Koivisto A, Matthias A, Bronnikov G, Nedergaard J. Kinetics of the inhibition of mitochondrial respiration by. FEBS Lett. 1997; 417: 75-80.
38. Laycock SK, Vogel T, Forfia PR et al. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ. Res. 1998; 82: 1263-71.
39. Deng A, Miracle CM, Suarez JM et al. Oxygen consumption in the kidney: Effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int. 2005; 68: 723-30.
40. Peroni O, Large V, Diraison F, Beylot M. Glucose production and gluconeogenesis in postabsorptive and starved normal and streptozotocin-diabetic rats. Metabolism 1997; 46: 1358-63.
41. Guder WG, Schmolke M, Wirthensohn G. Carbohydrate and lipid metabolism of the renal tubule in diabetes mellitus. Eur. J. Clin. Chem. Clin. Biochem. 1992; 30: 669-74.
42. O'Connor PM, Kett MM, Anderson WP, Evans RG. Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow. Am. J. Physiol. Renal Physiol. 2006; 290: F688-94.
43. Levy MN, Imperial ES. Oxygen shunting in renal cortical and medullary capillaries. Am. J. Physiol. 1961; 200: 159-62.
44. Aukland K. Studies on intrarenal circulation with special reference to gas exchange. J. Oslo City Hosp. 1964; 14: 115-46.
45. Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 2004; 6: 642-7.
46. Palm F, Ortsäter H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab. Res. Rev. 2004; 20: 452-9.
47. 2-regulated gene expression: Transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 2004; 96: 1173-7.
48. Haase VH. Hypoxia-inducible factors in the kidney. Am. J. Physiol. Renal Physiol. 2006; 291: F271-81.
49. Maxwell P. HIF-1: An oxygen response system with special relevance to the kidney. J. Am. Soc. Nephrol. 2003; 14: 2712-22.
50. Manotham K, Tanaka T, Ohse T et al. A biologic role of HIF-1 in the renal medulla. Kidney Int. 2005; 67: 1428-39.